Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 31;54(7):368–373. doi: 10.5483/BMBRep.2021.54.7.246

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 by the The Korean Society for Biochemistry and Molecular Biology

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 2 — Expressions of HERV-K Env and HERV-R Env proteins according to clinical factors. (A) Expressions of HERV-K Env and HERV-R Env proteins according to age group. (B) Expressions of HERV-K Env and HERV-R Env proteins according to the survival prognosis. (C) Expressions of HERV-K Env and HERV-R Env proteins according to gender. (D) Expressions of HERV-K Env and HERV-R Env proteins according to the stage of the tumor. (E) Expressions of HERV-K Env and HERV-R Env proteins according to other factors including differentiation, cancer type, and other markers or characteristics. The expression patterns of HERV-K Env and HERV-R Env proteins were compared based on the degree of differentiation in the liver, eso-phagus, and stomach cancer. The expression patterns of HERV-K Env and HERV-R Env proteins were also compared based on capsule involvement, tumor markers, and residual type in kidney cancer, breast cancer, and prostate cancer, respectively. (F) The expression patterns of HERV-K Env and HERV-R Env proteins were compared based on the tumor type in liver cancer, stomach cancer, ovarian cancer, kidney cancer, osteosarcoma, and esophagus cancer. Relative expressions of HERV-K Env and HERV-R Env were compared with the expressions in the surrounding normal tissues (% Normal).

Fig. 2 — Expressions of HERV-K Env and HERV-R Env proteins according to clinical factors. (A) Expressions of HERV-K Env and HERV-R Env proteins according to age group. (B) Expressions of HERV-K Env and HERV-R Env proteins according to the survival prognosis. (C) Expressions of HERV-K Env and HERV-R Env proteins according to gender. (D) Expressions of HERV-K Env and HERV-R Env proteins according to the stage of the tumor. (E) Expressions of HERV-K Env and HERV-R Env proteins according to other factors including differentiation, cancer type, and other markers or characteristics. The expression patterns of HERV-K Env and HERV-R Env proteins were compared based on the degree of differentiation in the liver, eso-phagus, and stomach cancer. The expression patterns of HERV-K Env and HERV-R Env proteins were also compared based on capsule involvement, tumor markers, and residual type in kidney cancer, breast cancer, and prostate cancer, respectively. (F) The expression patterns of HERV-K Env and HERV-R Env proteins were compared based on the tumor type in liver cancer, stomach cancer, ovarian cancer, kidney cancer, osteosarcoma, and esophagus cancer. Relative expressions of HERV-K Env and HERV-R Env were compared with the expressions in the surrounding normal tissues (% Normal).